Well we will have to see what pans out with any of the three acquisitions LOI. CBAI generally play with their cards close to their chest...its a smart strategy considering all the rhetoric that goes on around here. Last year they expanded through Stella and BioCell, RGI. And the placenta project. You should really follow this link: http://cordblood-america.com/investors/ir-blog
It's Matt Schissler's blog for investors, it details his plan for growth and revenue diversification. It will tell you everything you want to know. The mission statement says it all: CBAI wants to be the leader, the biggest and the best in the stem cell industry. The only way to get there is through growth. Thats why the properties they acquired last year weren't in the US-except RGI-CBAI is expanding onto the global market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.